The goal of this activity is to increase awareness in targeted treatments for rheumatoid arthritis (RA) and psoriatic arthritis (PsA), as well as the potential impact of biosimilar medicines in rheumatology clinical practice.

Earn Up To .75 Contact Hours With Our New Courses on Psoriatic Arthritis (PsA) Novel Targets, Novel Agents: How Our Newest Biologics Fit Into the […]

A chapter from HANDLING THE HARD QUESTIONS: What Our Patients Are Asking Us About Rheumatic Disease Read and download this booklet on our Workforce Resource […]

A chapter from HANDLING THE HARD QUESTIONS: What Our Patients Are Asking Us About Rheumatic Disease Read and download this booklet on our Workforce Resource […]

A chapter from HANDLING THE HARD QUESTIONS: What Our Patients Are Asking Us About Rheumatic Disease Read and download this booklet on our Workforce Resource […]

I first met AP, a 48-year-old woman, about 8 years ago when I was new at my current rheumatology practice. From the very start of […]

A few months ago, a new patient, SR, came into our office with a long and varied history of rheumatic disease. A 34-year-old Caucasian male […]

The treat-to-target approach to care is a hot topic in medicine and is now widely accepted as a best practice in our patients diagnosed with […]

A very long time ago in my nursing school days, I learned that each kidney has approximately 1 million nephrons comprised of convoluted tubules. Their […]

I have been caring for KN, a 57-year-old woman with psoriatic arthritis (PsA) for approximately 9 months. When she initially presented to our office, she […]

When I started in rheumatology practice 11 years ago, we had few options at our disposal to treat patients with psoriatic arthritis (PsA). The initial […]

There are a number of treatment guidelines/recommendations available in nearly every disease state that are based on high-quality clinical evidence. These guidelines typically take many […]

Treating patients with psoriatic arthritis (PsA) can be challenging when they fail to respond or lose their response to a specific therapy. Although we are […]

Two years ago, a 30-year-old woman (RB) came to our office for an initial consult. She was in a wheelchair, covered from head to toe […]